Загрузка...
Targeting T cells to treat atherosclerosis: odyssey from bench to bedside
More than 150 years from the initial description of inflammation in atherosclerotic plaques, randomized clinical trials to test anti-inflammatory therapies in atherosclerosis have recently been initiated. Lymphocytes and macrophages are main participants in the inflammatory response in atheroscleros...
Сохранить в:
| Опубликовано в: : | Eur Heart J Cardiovasc Pharmacother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907356/ https://ncbi.nlm.nih.gov/pubmed/27418972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcvp/pvw001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|